Obagi Skintrinsiq Clarifiying Protocol
- Product NDC
- 62032-909
- 11-digit product format
- 620320909
- Labeler code
- 62032
- Product ID
- 62032-909_a9c17c57-a3af-43d6-9db3-56fb8e28894b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- salicylic acid, titanium dioxide, and zinc oxide
- Dosage form
- KIT
- Labeler
- Obagi Cosmeceuticals LLC
- Application
- M020
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-08-01
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 62032-909-09 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 62032-909-09 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 62032-909-09 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 62032-909-09 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 62032-909-09 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 62032-909-09 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 62032-909-09 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Obagi Skintrinsiq Clarifiying Protocol
- Listing expiration
- 2026-12-31
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 08ba9ea8-73fd-472b-9cc4-67df167352ec | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
| 7792dadb-52b6-46b6-8fdf-80b1171065b5 | Product name | 1 | 20180810 |
| 9869efd7-d6dd-0665-5b67-53adbe6ef15e | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| Effective | Related label |
|---|---|
| 2025-04-01 | Obagi ® Skintrinsiq™ Clarifiying Protocol Kit |
| 2025-01-30 | Obagi ® Skintrinsiq™ Clarifiying Protocol Kit |
| 2023-03-29 | Obagi ® Skintrinsiq™ Clarifiying Protocol Kit |
| 2023-01-30 | Obagi ® Skintrinsiq™ Clarifiying Protocol Kit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62032-612-04 | Obagi Skintrinsiq Clarifiying Protocol | 148 mL in 1 BOTTLE, PLASTIC | LIQUID | 148 mL | 20 mg in 1mL | 3 |
| 62032-811-09 | Obagi Skintrinsiq Clarifiying Protocol | 1 in 1 CARTON | LOTION | 15.6 g in 100g | 3 | |
| 62032-811-09 | Obagi Skintrinsiq Clarifiying Protocol | 85 g in 1 TUBE | LOTION | 85 g | 15.6 g in 100g | 3 |
| 62032-909-09 | Obagi Skintrinsiq Clarifiying Protocol | 1 in 1 BOX | KIT | 1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62032-909 | OBAGI SKINTRINSIQ CLARIFIYING PROTOCOL (SALICYLIC ACID, TITANIUM DIOXIDE, AND ZINC OXIDE) KIT [OBAGI COSMECEUTICALS LLC] | 3 | Current NDC, Legacy NDC, 4 package rows | 20250406_08ba9ea8-73fd-472b-9cc4-67df167352ec.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Daily Dose Bioretinol Mineral SPF 40 | ZINC OXIDE | Supergoop, LLC | eb5bbc70-dbdf-06a8-e053-2995a90a66c1 | 2026-01-09 | Warnings | M020 |
| Unseen Sunscreen Body SPF 40 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | Supergoop, LLC | ec1c30bd-76e1-9d00-e053-2a95a90a1759 | 2026-01-09 | Warnings | M020 |
| Glow Screen SPF 40 | AVOBENZONE, OCTISALATE, OCTOCYLENE | Supergoop, LLC | 21569637-332a-461b-bf6c-33af6a83a155 | 2026-01-09 | Warnings | M020 |
| Glowscreen SPF 40 - Dawn | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | Supergoop, LLC | f07145d5-b74d-7757-e053-2a95a90ac4c0 | 2026-01-09 | Warnings | M020 |
| Glowscreen SPF 40 -Sunset | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | Supergoop, LLC | f7e493da-8fc6-191d-e053-6294a90aa483 | 2026-01-09 | Warnings | M020 |
| Supergoop Glow Screen SPF 40 Shade 2 Golden Hour | BROAD SPECTRUM SUNSCREEN | Supergoop LLC | d2928dd7-a813-4929-e053-2a95a90aaeb4 | 2026-01-09 | Warnings | M020 |
| Superscreen Hydrating Daily Cream SPF 40 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | Supergoop, LLC | ff0e4e97-8f01-bd36-e053-6394a90a47ae | 2026-01-09 | Warnings | M020 |
| Lipshade SPF 30 Hey Yall | ZINC OXIDE | Supergoop, LLC | f93dfa13-ff18-ee38-e053-6394a90aea46 | 2026-01-09 | Warnings | M020 |
| Triple Prep SPF 40 | AVOBENZONE, OCTISALATE, OCTOCRYLENE, HOMOSALATE | Supergoop, LLC | 004df4e5-dba9-6030-e063-6394a90a76d3 | 2026-01-09 | Warnings | M020 |
| Unseen Sunscreen Lip Protector SPF 30 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | Supergoop, LLC | 12605fb4-0de6-94f3-e063-6294a90a3a6f | 2026-01-09 | Warnings | M020 |
| Unseen Sunscreen Stick SPF 40 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | Supergoop, LLC | 2735c5c7-a4ef-33c3-e063-6294a90abf97 | 2026-01-09 | Warnings | M020 |
| PLAY Sunscreen SPF 50 | HOMOSALATE, OCTOCRYLENE, OCTISALATE, AVOBENZONE | Supergoop LLC | 2860d42c-d644-8b5a-e063-6394a90aec10 | 2026-01-09 | Warnings | M020 |
| PLAY Mineral SPF 30 with Green Algae | ZINC OXIDE | Supergoop LLC | 29a1ff4b-3875-5275-e063-6394a90a53fd | 2026-01-09 | Warnings | M020 |
| Every. Single. Face. Watery SPF 50 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE | Supergoop, LLC | d086a9b8-19e5-f713-e053-2995a90aa976 | 2026-01-09 | Warnings | M020 |
| 3D Tinted Moisturizing BS SPF 30 | ZINC OXIDE | Allure Labs | 47fd415f-819e-bbb8-e063-6394a90a2c6a | 2026-01-09 | Warnings | M020 |
| ST MORIZ SUNCARE BODY SUNSCREEN SPF50 | SUNCARE BODY SUNSCREEN SPF50 | Aopline Biotechnology (Guangzhou) Co., Ltd. | 4801cfd2-1fe2-d118-e063-6294a90a6c8b | 2026-01-09 | Warnings | M020 |
| ST MORIZ SUNCARE BODY SUNSCREEN SPF30 | SUNCARE BODY SUNSCREEN SPF30 | Aopline Biotechnology (Guangzhou) Co., Ltd. | 48026f09-6d15-8fa6-e063-6294a90a17cb | 2026-01-09 | Warnings | M020 |
| RODAN and FIELDS ENHANCEMENTS MEDIUM | TITANIUM DIOXIDE, ZINC OXIDE | Bentley Laboratories, LLC | 6aa6ad3f-2c52-4031-9e6c-7526c42de71d | 2026-01-09 | Warnings | M020 |
| FACE SPF 47 SETTING | FACE SPF 47 SETTING SPRAY | Aopline Biotechnology (Guangzhou) Co., Ltd. | 47db9a54-c02f-d2ea-e063-6394a90ab973 | 2026-01-08 | Warnings | M020 |
| BADABOOM SUNSCREEN | SUNSCREEN | Aopline Biotechnology (Guangzhou) Co., Ltd. | 47dbf363-2892-4530-e063-6294a90abe1f | 2026-01-08 | Warnings | M020 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1235208 | CLENZIderm M.D. 2 % Pore Therapy Topical Solution | PSN | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 251577 | salicylic acid 2 % Topical Solution | PSN | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 1235208 | salicylic acid 20 MG/ML Topical Solution [Clenziderm] | SBD | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 251577 | salicylic acid 20 MG/ML Topical Solution | SCD | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 1235208 | Clenziderm 20 MG/ML Topical Solution | SY | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 1235208 | Clenziderm M.D. 2 % Pore Therapy | SY | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
| 251577 | salicylic acid 2 % Topical Solution | SY | 08ba9ea8-73fd-472b-9cc4-67df167352ec | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 62032-612-04 | 62032061204 | 148 mL in 1 BOTTLE, PLASTIC | 148 ml | Historical | ||||
| 62032-811-09 | 62032081109 | 1 in 1 CARTON | Historical | |||||
| 62032-909-09 | 62032090909 | 1 KIT in 1 BOX (62032-909-09) * 148 mL in 1 BOTTLE, PLASTIC (62032-612-04) * 1 BOTTLE, PUMP in 1 CARTON / 48 g in 1 BOTTLE, PUMP * 1 TUBE in 1 CARTON (62032-811-09) / 85 g in 1 TUBE * 59 mL in 1 BOTTLE, PLASTIC * 60 mL in 1 BOTTLE, PLASTIC | 1 kit | 2021-08-01 | 0000-00-00 | No | No | Current |